Found: 1
Select item for more details and to access through your institution.
The association between anthropometric indicators of obesity and cardiac reverse remodelling with empagliflozin in patients with type 2 diabetes and coronary artery disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2765, doi. 10.1111/dom.15119
- By:
- Publication type:
- Article